These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 2455485)

  • 21. Interstitial matrix proteins determine hyaluronan reflection and fluid retention in rabbit joints: effect of protease.
    Sabaratnam S; Coleman PJ; Mason RM; Levick JR
    J Physiol; 2007 Jan; 578(Pt 1):291-9. PubMed ID: 17008373
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterization of the coupling activity for the binding of inter-alpha-trypsin inhibitor to hyaluronan in human and bovine follicular fluid.
    ØDum L; Andersen CY; Jessen TE
    Reproduction; 2002 Aug; 124(2):249-57. PubMed ID: 12141938
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Covalent linkage between proteins of the inter-alpha-inhibitor family and hyaluronic acid is mediated by a factor produced by granulosa cells.
    Chen L; Zhang H; Powers RW; Russell PT; Larsen WJ
    J Biol Chem; 1996 Aug; 271(32):19409-14. PubMed ID: 8702628
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The source of the inter-alpha trypsin inhibitor in pathologic hyaluronateprotein.
    Becker A; Sandson J
    Arthritis Rheum; 1971; 14(6):764-6. PubMed ID: 5002739
    [No Abstract]   [Full Text] [Related]  

  • 25. Biochemical effect of intra-articular injections of high molecular weight hyaluronate in rheumatoid arthritis patients.
    Matsuno H; Yudoh K; Kondo M; Goto M; Kimura T
    Inflamm Res; 1999 Mar; 48(3):154-9. PubMed ID: 10219658
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inflammatory mediators and modulators released in organ culture from rabbit skin lesions produced in vivo by sulfur mustard. III. Electrophoretic protein fractions, trypsin-inhibitory capacity, alpha 1-proteinase inhibitor, and alpha 1- and alpha 2-macroglobulin proteinase inhibitors of culture fluids and serum.
    Harada S; Dannenberg AM; Vogt RF; Myrick JE; Tanaka F; Redding LC; Merkhofer RM; Pula PJ; Scott AL
    Am J Pathol; 1987 Jan; 126(1):148-63. PubMed ID: 2433944
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Matrix-degrading protease ADAMTS-5 cleaves inter-α-inhibitor and releases active heavy chain 2 in synovial fluids from arthritic patients.
    Scavenius C; Poulsen EC; Thøgersen IB; Roebuck M; Frostick S; Bou-Gharios G; Yamamoto K; Deleuran B; Enghild JJ
    J Biol Chem; 2019 Oct; 294(42):15495-15504. PubMed ID: 31484722
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Protease inhibitors in rheumatoid synovial fluid. Analyses of electrophoretic homogeneity and protease inhibitory capacity.
    Ekerot L; Ohlsson K
    Rheumatol Int; 1982; 2(1):21-6. PubMed ID: 6184771
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Do synovial fluid acute phase proteins from patients with rheumatoid arthritis originate from serum?
    Havenaar EC; Dolhain RJ; Turner GA; Goodarzi MT; van Ommen EC; Breedveld FC; van Dijk W
    Glycoconj J; 1997 Jun; 14(4):457-65. PubMed ID: 9249143
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Trypsin-2 degrades human type II collagen and is expressed and activated in mesenchymally transformed rheumatoid arthritis synovitis tissue.
    Stenman M; Ainola M; Valmu L; Bjartell A; Ma G; Stenman UH; Sorsa T; Luukkainen R; Konttinen YT
    Am J Pathol; 2005 Oct; 167(4):1119-24. PubMed ID: 16192646
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Altered properties of pathological hyaluronate due to a bound inter-alpha trypsin inhibitor.
    Sandson J; Hamerman D; Schwick G
    Trans Assoc Am Physicians; 1965; 78():304-13. PubMed ID: 4955886
    [No Abstract]   [Full Text] [Related]  

  • 32. Detection of citrullinated proteins in synovial fluids derived from patients with rheumatoid arthritis by proteomics-based analysis.
    Tabushi Y; Nakanishi T; Takeuchi T; Nakajima M; Ueda K; Kotani T; Makino S; Shimizu A; Hanafusa T; Takubo T
    Ann Clin Biochem; 2008 Jul; 45(Pt 4):413-7. PubMed ID: 18583628
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differences between the binding of trypsin and chymotrypsin by alpha 1-proteinase inhibitor.
    Hercz A
    Biochem Biophys Res Commun; 1986 Jul; 138(2):925-30. PubMed ID: 3488739
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Biochemical analysis of rheumatoid synovial fluid after serial intra-articular injection of high molecular weight sodium hyaluronate.
    Goto M; Hosako Y; Katayama M; Yamada T
    Int J Clin Pharmacol Res; 1993; 13(3):161-6. PubMed ID: 8225699
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Protease inhibitors in inflammatory synovial effusions.
    Hadler NM; Johnson AM; Spitznagel JK; Quinet RJ
    Ann Rheum Dis; 1981 Feb; 40(1):55-9. PubMed ID: 7469525
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relations between synovial fluid and serum concentrations of osteocalcin and other markers of joint tissue turnover in the knee joint compared with peripheral blood.
    Salisbury C; Sharif M
    Ann Rheum Dis; 1997 Sep; 56(9):558-61. PubMed ID: 9370881
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Functionally active alpha2-macroglobulin and kinen release in synovial fluids of rheumatoid arthritis.
    Hamberg U; Vahtera E; Moilanen L
    Agents Actions; 1978 Jan; 8(1-2):50-6. PubMed ID: 76438
    [No Abstract]   [Full Text] [Related]  

  • 38. Synovial fluid is a site of citrullination of autoantigens in inflammatory arthritis.
    Kinloch A; Lundberg K; Wait R; Wegner N; Lim NH; Zendman AJ; Saxne T; Malmström V; Venables PJ
    Arthritis Rheum; 2008 Aug; 58(8):2287-95. PubMed ID: 18668562
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Concentration and molecular weight distribution of hyaluronate in synovial fluid from clinically normal horses and horses with diseased joints.
    Tulamo RM; Heiskanen T; Salonen M
    Am J Vet Res; 1994 May; 55(5):710-5. PubMed ID: 8067622
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Protective factors against oxygen free radicals and hydrogen peroxide in rheumatoid arthritis synovial fluid.
    Biemond P; Swaak AJ; Koster JF
    Arthritis Rheum; 1984 Jul; 27(7):760-5. PubMed ID: 6743361
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.